Study in Healthy Adults Evaluating PF-07202954

NCT04857437 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Alcoholic Fatty Liver Disease
Liver Fibrosis

Interventions

DRUG: PF-07202954 Repeat Dose
DRUG: PF-07202954 Single Dose
DRUG: Placebo

Sponsor

Pfizer